Michael G. Fehlings(@DrFehlings) 's Twitter Profileg
Michael G. Fehlings

@DrFehlings

Scientist and Neurosurgeon interested in spinal cord injury & regenerative medicine

ID:92301201

linkhttp://www.drfehlings.ca calendar_today24-11-2009 15:53:41

3,7K Tweets

4,9K Followers

279 Following

Follow People
Krembil Brain Institute(@KBI_UHN) 's Twitter Profile Photo

EP 3 of Krembil Brain Institute's podcast is out! “25 Years of Momentum in Spinal Cord Injury Research” features University Health Network's Michael G. Fehlings & Dr. Laureen Hachem. Hear an incredible personal account of living with a from John Ruffolo.

Listen & subscribe -> bit.ly/4aT8l0k

account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

Looking forward to moderating this AO Spine Intraoperative Ultrasound Pre-course at the Global Spine Congress in May. The program looks great - hope to see you there!

Looking forward to moderating this @AOSpine Intraoperative Ultrasound Pre-course at the Global Spine Congress in May. The program looks great - hope to see you there!
account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

Congratulations to Dr.Karlo Pedro, one of our Spine Program, University of Toronto Fellows, for receiving the top research prize at the AO Spine North America Fellows Forum for his paper on machine learning-based cluster analyses to identify phenotypes of DCM patients with distinct clinical profiles and outcomes

Congratulations to Dr.Karlo Pedro, one of our @UofTSpine Fellows, for receiving the top research prize at the @AOSpineNA Fellows Forum for his paper on machine learning-based cluster analyses to identify phenotypes of DCM patients with distinct clinical profiles and outcomes
account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

Interesting Editorial entitled 'Unraveling the controversy: high-dose steroids in spinal cord injury. Forty years of inquiry' authored by Drs. Rispoli and Cappelletto

pubmed.ncbi.nlm.nih.gov/38483436/

account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

I enjoyed appearing on The Spineline Podcast alongside Dr. Karlo Pedro to discuss the shifting demographics of spinal cord injury. Check it out! NASS Spine Program, University of Toronto
youtube.com/watch?v=E3Utoa…

account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

I recently spoke at the 2024 British Association of Spine Surgeons meeting on indications for surgery in spine trauma and on clinical applications of spinal biomechanics. A fantastic meeting and I am glad I had the opportunity to attend! Spine Program, University of Toronto U of T Department of Surgery Krembil Brain Institute

I recently spoke at the 2024 British Association of Spine Surgeons meeting on indications for surgery in spine trauma and on clinical applications of spinal biomechanics. A fantastic meeting and I am glad I had the opportunity to attend! @UofTSpine @UofTSurgery @KBI_UHN
account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

Looking forward to giving a talk titled 'Degenerative Cervical Myelopathy - What is New? What is Hot?' on March 26th at 9 PM CET as part of the NSURG TO GO online course series!

nsurg.medizintogo.de/course/2853

account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

Karlo Pedro, PhD student in the Fehlings Lab, presenting at the Canadian Spine Society meeting. His talk focused on a re-analysis of the CSM-Protect trial, which shows a global benefit of riluzole in patients with DCM undergoing surgical management. U of T Department of Surgery University of Toronto Neurosurgery

Karlo Pedro, PhD student in the Fehlings Lab, presenting at the @spinecanada meeting. His talk focused on a re-analysis of the CSM-Protect trial, which shows a global benefit of riluzole in patients with DCM undergoing surgical management. @UofTSurgery @UofTNeuroSurge
account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

A great day at SpineSummit2024! I presented a re-analysis of CSM-Protect using a Global Statistical Test, which shows striking improvement with riluzole in patients with DCM undergoing surgical treatment. I also enjoyed debating Dr. Mo Bydon, where I lobbied for Time is Spine!

A great day at SpineSummit2024! I presented a re-analysis of CSM-Protect using a Global Statistical Test, which shows striking improvement with riluzole in patients with DCM undergoing surgical treatment. I also enjoyed debating Dr. Mo Bydon, where I lobbied for Time is Spine!
account_circle
Michael G. Fehlings(@DrFehlings) 's Twitter Profile Photo

New Article: The Shifting Demographics of Spinal Cord Injury: Important Implications for Medicine and Society

spinelinemag.spine.org/janfeb24/invit…

account_circle